A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction
Nat Commun. 2025 Oct 23;16(1):9381. doi: 10.1038/s41467-025-64324-y. ABSTRACT Maternal vaccines to prevent infant Group B Streptococcus (GBS) disease have progressed through phase II development and …